Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1992-8-6
pubmed:abstractText
An Escherichia coli strain, B-62, that was isolated from a clinical source and was epidemiologically unrelated to E. coli K-12 was the source of chromosomal DNA for a sucrose utilization system (Scr+) in the construction of a plasmid, pST621. The cloned insert of a gene encoding Scr+ in pST621 conferred a sucrose-positive phenotype onto transformed cells of E. coli K-12 derivatives. Sucrase activity of the transformants was as high as that which would correspond to a "gene dosage effect" of a vector plasmid pBR322, whereas the transformants' sucrose uptake activity was always lower than that of E. coli B-62. A region within an XhoI-SacI fragment (3.2 kb) of pBR322-glyA was replaced in the construction of another plasmid, pST5R7, by a fragment (about 2.6 kb) of pST622 containing the gene encoding Scr+. A genetically stable Scr+ derivative of E. coli K-12 was obtained by introducing the gene encoding Scr+ onto E. coli chromosome via homologous recombination between pST5R7 and the chromosome and subsequent plasmid segregation. The use of low-copy-number plasmid RP4 as a cloning vector was also effective for enhancing the stability of Scr+. Tryptophan producers E. coli SGIII1032S, in which the gene encoding Scr+ was cloned onto the chromosome, and E. coli SGIII1032, which carried Scr+ plasmid RP4.5R7, produced from 6% sucrose in shake flasks (33 degrees C, 96 h) 2.3 and 5.7 g of tryptophan per liter, respectively.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-1092649, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-1094091, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-2166474, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-3034863, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-3112516, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-3548588, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-372492, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-388356, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-3911031, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-4568763, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-4605400, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-6202587, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-6211435, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-6268607, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-6811836, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-6999123, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-7021324, http://linkedlifedata.com/resource/pubmed/commentcorrection/1622287-7036897
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0099-2240
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2081-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Acquisition of a sucrose utilization system in Escherichia coli K-12 derivatives and its application to industry.
pubmed:affiliation
Mercian Co., Central Research Laboratories, Kanagawa, Japan.
pubmed:publicationType
Journal Article